Companies In Pharmaceutical Sector Research Articles

Pengaruh Pengungkapan Akuntansi Karbon Kinerja Lingkungan Terhadap Profitabilitas Perusahaan Sektor Farmasi Yang Terdaftar di BEI Tahun 2022

The aim of this research is to find out the effect of accounting disclosures on the profitability of pharmaceutical sector companies in 2022. A quantitative approach is the method in this research. This type of research data is secondary data taken from annual reports and company sustainability reports via the idx.com data site and the company's official website. The population is 30 pharmaceutical sector companies listed on the IDX. The sample was used in 5 companies that met the required data criteria. The research collection technique used was SPSS 24. The results obtained from this research were that simultaneously disclosing carbon accounting and environmental performance had an effect on the profitability of pharmaceutical sector companies in 2022.

PENGARUH UKURAN PERUSAHAAN, LIKUIDITAS, DAN PERTUMBUHAN PENJUALAN TERHADAP PROFITABILITAS PADA PERUSAHAAN SEKTOR FARMASI YANG TERDAFTAR DI BURSA EFEK INDONESIA

The purpose of this research is to examine and analyze the influence of company size, liquidity and sales growth on profitability in pharmaceutical sector companies listed on the Indonesia Stock Exchange. The approach used in this research is quantitative, using secondary data in the form of financial reports. This research is a population study taken from the financial reports of 10 pharmaceutical sector companies for the 2018-2021 period. Data analysis used descriptive analysis, classical assumption test, multiple linear regression, t test, f test and coefficient of determination using the SPSS version 24 program. Research results This shows that company size, liquidity and sales growth simultaneously have a significant effect on profitability. Partially, company size has a significant negative effect on profitability, liquidity has a significant positive effect on profitability, then sales growth has a significant positive effect on profitability in pharmaceutical sector companies listed on the Indonesia Stock Exchange.Keywords: Company Size; Liquidity; Sales Growth; Profitability

PENGARUH STRUKTUR MODAL, PROFITABILITAS, DAN UKURAN PERUSAHAAN TERHADAP NILAI PERUSAHAAN DENGAN HARGA SAHAM SEBAGAI VARIABEL INTERVENING PADA PERUSAHAAN SEKTOR FARMASI YANG TERDAFTAR DI BEI PADA TAHUN 2019-2022

The aim of the research is to analyze and test the influence of capital structure, profitability and company size on company value through share prices. The populations in this study are pharmaceutical sector companies listed on the IDX in 2019-2022. The sampling technique used is non-probability sampling using purposive sampling technique. The data analysis and hypothesis testing in this research used the Structural Equation Model - Partial Least Square (PLS-SEM). The results of direct hypothesis testing show that capital structure has no significant effect on stock prices, the profitability has a significant effect on stock prices, the company size has no significant effect on stock prices, the capital structure has no significant effect on company value, the profitability has no significant effect on company value, and the company size has significant effect on company value. The results of the indirect influence hypothesis test show that capital structure has no significant effect on company value through share prices, the profitability has no significant effect on company value through share prices, and the company size has no significant effect on company value through share prices..

The Impact of Transfer Pricing, Capital Intensity, Thin Capitalization on Tax Avoidance with Sales Growth as Moderating Variabel in Pharmaceutical and Health Companies Listed on Indonesia Stock Exchange 2017-2022

In Indonesia, current tax regulations aim to address these practices through rules like transfer pricing, restrictions on interest deductions on loans from affiliated companies (thin capitalization rules), and asset depreciation rules. However, companies often seek loopholes or new strategies to reduce their tax obligations. This study aims to evaluate the impact of transfer pricing, capital intensity, and thin capitalization on tax avoidance practices in the health and pharmaceutical sector in Indonesia. This is particularly relevant as health sector companies listed on the Indonesia Stock Exchange saw an average revenue increase of 6% during the overall economic downturn caused by the Covid-19 pandemic, reflecting the growing public awareness of health importance and efforts to maintain health during the pandemic. The data for this study is obtained from the financial statements of health and pharmaceutical sector companies listed on the Indonesia Stock Exchange from 2017 to 2022, selected through purposive sampling, with a total of 132 observations sourced from www.idx.co.id. The analysis method used was panel data regression analysis, with Gross Profit Margin (TA_GM) used as a proxy. The results show that transfer pricing, capital intensity, and thin capitalization have a positive impact on tax avoidance. However, sales growth does not enhance the influence of these independent variables on tax avoidance. These findings are expected to assist the Tax and Financial Services Authority in enhancing regulations related to tax avoidance in Indonesia, aligning with the reduction of tax avoidance practices in the health and pharmaceutical sector, and increasing state tax revenues.

Pengaruh NPM dan Current Ratio terhadap Financial Sustainability pada Perusahaan Farmasi yang Terdaftar di BEI Tahun 2014-2022

This study aims to determine the effect of Net Profit Margin (NPM) and Current Ratio on Financial Sustainability (FSR) in Pharmaceutical Sector Companies Listed on the IDX. The sample used in this research is 2 pharmaceutical sector companies listed on the Indonesia Stock Exchange for the period 2014 - 2022 and using purposive sampling method. The data analysis technique used is quantitative analysis. The data analysis method used is hypothesis testing including the F statistical test and the t statistical test. The results obtained in this study indicate that there is a significant effect of Net Profit Margin (NPM) and Current Ratio together on Financial Sustainability (FSR). Based on partial tests, there is a significant effect of Net Profit Margin (NPM) on Financial Sustainability (FSR). While Current Ratio has no significant effect on Financial Sustainability (FSR) in Pharmaceutical Sector Companies Listed on the IDX.

Detection of Financial Statement Fraud by Using the Beneish Ratio Index in Health and Pharmaceutical Sector Companies Listed on the Indonesia Stock Exchange (IDX) in 2020 – 2022

Detection of Financial Statement Fraud by Using the Beneish Ratio Index in Health and Pharmaceutical Sector Companies Listed on the Indonesia Stock Exchange (IDX) in 2020 – 2022

ANALISIS PERBANDINGAN AGRESIVITAS PAJAK SEBELUM DAN SESUDAH PANDEMI COVID-19 PADA PERUSAHAAN FARMASI

The Covid-19 pandemic has resulted in a decrease in state revenue and an increase in state spending, which prompted the Indonesian government to issue fiscal policy as an effort to save the national economy. However, in this context, tax avoidance practices by pharmaceutical sector companies are a significant problem, with the Tax Justice Network recording lost tax revenues reaching US $ 4.86 billion per year or equivalent to Rp69.1 trillion. This study aims to empirically examine the Tax Avoidance of Pharmaceutical Sector Companies Before and After the Covid-19 Pandemic. This study uses the Effective Tax Ratio (ETR) as a proxy or measure of tax avoidance. This type of research is descriptive research, using secondary data on the company's financial statements with data analysis techniques using the Paire sample T-Test. The population of this study is pharmaceutical sector companies listed on the Indonesia Stock Exchange (IDX) in 2018-2019 and 2021-2022. The results prove that there are differences in tax aggressiveness before and after the Covid-19 pandemic. The Covid-19 pandemic has had a significant impact on the practice of tax aggressiveness of pharmaceutical sector companies in Indonesia, as evidenced by the difference in tax avoidance before and after the Covid-19 pandemic based on the Effective Tax Ratio (ETR) proxy.

Pengaruh Intellectual Capital dan Enterprise Risk Management Terhadap Nilai Perusahaan dengan Kinerja Keuangan sebagai Variabel Intervening (pada Perusahaan Farmasi yang Terdaftar di Bursa Efek Indonesia Periode 2018-2021)

Price book value is an indicator of company value that is usually used as an assessment by investors when investing. This research aims to obtain the results of a study of the influence of intellectual capital with the value added intellectual capital (VAIC) indicator and enterprise risk management with the indicator (COSO ERM) on company value and financial performance as intervening variables in pharmaceutical sector companies listed on the Indonesia Stock Exchange for the 2018 period. -2021. The method used was purposive sampling so that a sample of 9 companies was obtained. Data analysis uses partial least squares (PLS). The research results show that intellectual capital, enterprise risk management and financial performance directly have a positive and significant effect on company value. The research results also state that intellectual capital and enterprise risk management which are mediated by financial performance variables have a positive influence on company value.

Stock Performance Analysis of PT. Kalbe Farma TBK (KLBF) in 2016-2020

When the World Health Organization (WHO) announced that COVID-19 was upgraded to pandemic status, investors began to reconsider their portfolio structure from risky assets such as stocks to gold. This study aims to determine the stock performance of PT. Kalbe Farma Tbk during the COVID-19 pandemic. A quantitative descriptive approach by linking company financial statement data with the phenomenon of the COVID-19 pandemic is the method used in this study. Based on the results of the research that has been done, it can be concluded that the performance of PT. Kalbe Farma Tbk before and during the COVID-19 pandemic on the dependent variable (stock return), namely the Current ratio, had a significant effect on Stock Return. However, based on the results of hypothesis testing regarding the effect of Earnings Per Share and Net profit margin on Stock Return partially, it can be concluded that these variables do not have a significant effect on Stock Return. Based on the conclusions above, the researcher recommends that the first company is expected to make the value of CR better in order to attract investors in investing their funds. Because if the company has a high CR value then the company can be said to have no constraints to pay its debts, thus many investors will be interested in investing in pharmaceutical sector companies and that can be very profitable for the company. Next is advice for those who want to invest in pharmaceutical companies, it is recommended to look at the CR owned by the company if investors want to make long-term investments.

Faktor yang Berpengaruh pada Nilai Perusahaan (Emite sektor Farmasi di BEI Tahun 2019-2021)

This study aims to analyze and obtain empirical evidence regarding the influence of slack resources, leverage, company size and corporate social responsibility disclosure. The population of this study is 12 pharmaceutical sector companies listed on the Indonesia Stock Exchange from 2019 to 2021. Based on the criteria, 10 pharmaceutical sector companies that have been obtained to be used as research samples. This study used the SPSS version 26 analysis test. The data analysis techniques used are classical assumption tests, multiple linear regression tests, and hypothesis tests. The results showed that, partially, leverage affects the value of the company, while slack resources, leverage, company size and disclosure of corporate social responsibility do not affect the value of the company.

Kinerja Keuangan dan Nilai Perusahaan Sektor Farmasi

Companies have goals to be achieved. The company's efforts aim to produce sound financial performance and increase firm value. Many factors can determine the value of a company. This research aims to obtain a depiction of the performance and value of the company. In addition, testing and analyzing the influence of financial performance factors on firm value is also the aim of this study. The research sample is pharmaceutical sector companies listed on the Indonesia Stock Exchange. Secondary data was obtained from financial statements for five years and processed using regression analysis. The results showed that the indicators measuring liquidity, leverage, activity, profitability, and company size contributed to determining firm value. Specifically, the test results show that the ability of pharmaceutical companies to meet current liabilities as the maturity date is a factor determining firm value.

Pengaruh Economic Value-Added dan Market Value Added terhadap Harga Saham pada Perusahaan Sektor Healthcare

According to the Central Statistics Agency (BPS) (2020), the economic sector experienced a sharp decline in income during the Covid-19 pandemic, which ranged from 70.67% to 87.93%. However, it is inversely proportional to the pharmaceutical sector companies which have experienced an increase in sales of goods and services, this is due to the fact that during the pandemic medical devices became the main needs of the general public. Seeing this phenomenon, the authors conducted a study that aimed to find out the effect of EVA and MVA on stock prices in Healthcare sector companies listed on the Indonesia Stock Exchange for the 2019-2022 period. The author uses purposive sampling method in this study. The results of this study show that partially, Economic Value Added does not have a significant effect on stock prices, while Market Value Added has a significant influence on stock prices. Simultaneously, Economic Value Added and Market Value Added affect the share price of Healthcare companies on the Indonesia Stock Exchange for the 2019-2022 period.

Relationship between Company Size, EPS, Leverage and Financial Performance of Pharmaceutical Companies on the IDX

Objectives – This research aims to determine the influence of company size, EPS, and leverage on the financial performance of manufacturing industry companies in the pharmaceutical sub-sector listed on the IDX. Design/Methodology/Approach – This research uses secondary data from financial reports of pharmaceutical companies on the Indonesia Stock Exchange in 2018 - 2022. The sample used was 8 companies with sample selection using purposive sampling technique. The analysis used is multiple linear regression with the Eviews 9.0 analysis tool. Findings – The results of this study show that Company Size has no effect on financial performance, EPS has a significant effect on financial performance, Leverage has no effect on financial performance. Conclusions and Implications - Based on the results, it is found that company size has no effect on financial performance, while EPS has a positive effect on financial performance and leverage has a negative effect on financial performance. Pharmaceutical sector companies listed on the IDX can increase EPS and reduce leverage to improve financial performance.

PENGARUH LIKUIDITAS DAN PROFITABILITAS TERHADAP NILAI PERUSAHAAN DENGAN KEBIJAKAN DIVIDEN SEBAGAI VARIABEL INTERVENING PADAPERUSAHAAN FARMASI YANG TERDAFTAR DI BEI

Pharmaceutical companies are companies whose production focuses on medicines and health The value of a company can basically be measured in several ways, one of which is the company's stock price. The purpose of this study was to determine the significance of the effect of Liquidity and Profitability on Firm Value of Dividend Policy. This research uses descriptive and quantitative research The population in this study are 12 pharmaceutical sector companies listed on the Indonesia Stock Exchange for the 2018-2021 period The sampling technique in this study used a purposive sampling technique. Data analysis and hypothesis testing in this study used the Structural Equation Model-Partial Least Square (PLS-SEM)
 The results of the direct influence hypothesis test using the Smart PLS 3.0 application, show that Liquidity has a negative but significant effect on Dividend Policy, Profitability has a positive but not significant effect on Dividend Policy, Liquidity has a significant positive effect on Company Value, Profitability has a significant positive effect on Company Value, Profitability has an effect positive but not significant to company value. The results of the indirect influence hypothesis test show that the variable Liquidity on Dividend Policy through Company Value has a positive but not significant effect, Profitability on Dividend Policy through Company Value has a negative but not significant effect.

Analisis Praktik Corporate Social Responsibility (CSR) Saat Pandemi Covid-19 pada Perusahaan Farmasi

This study aims to analyze: 1) the level and quality of Corporate Social Responsibility (CSR) disclosure during the Covid-19 in pharmaceutical companies based on the 2021 GRI Standards, 2) Corporate Social Responsibility (CSR) practiced by pharmaceutical companies in helping to overcome the Covid-19 based on the 2021 GRI Standards. This research is a qualitative research using content analysis methods. The research was conducted on pharmaceutical sector companies in Indonesia by taking 4 samples of companies, namely PT Indofarma Tbk, PT Kalbe Farma Tbk, PT Phapros Tbk, and PT Sido Muncul Tbk. The data used is data for 2019-2020 when the Covid-19 entered Indonesia. The research data comes from the company's sustainability report. The results of content analysis show that the Covid-19 has played a major role in the disclosure of Corporate Social Responsibility (CSR) in the pharmaceutical sector. Two of the four companies that were the subject of the study had quite high Corporate Social Responsibility (CSR) disclosures, namely PT Kalbe Farma and PT Sido Muncul Tbk. Four companies that are active research subjects provide assistance in the form of donations to the community in efforts to tackle the Covid-19.

Pengaruh Inflasi, Tingkat Suku Bunga, Nilai Tukar, dan Struktur Modal terhadap Return Saham Perusahaan Sektor Farmasi

Return is one of the factors that can motivate investors to invest. There are two factors that can affect the rate of return, there are macro and microeconomic factors This study aims to determine the effect of macroeconomic factors, such as inflation, interest rates, and exchange rates and microeconomic factors, there are capital structure on stock returns in pharmaceutical sector companies listed in Indonesia Stock Exchange for the 2015-2020 period. This research is a quantitative approach, there are calculations on the data in the form of numbers. The research sample uses pharmaceutical companies that have been listed on the IDX for the 2015-2020 period using a purposive sampling technique, obtained 48 samples of the company during the 2015-2020 period. The research is secondary data which is already available about financial reports and annual reports of pharmaceutical sector companies for the 2015-2020 period and obtained from Indonesian Stock Exchange official website. The results showed that inflation have a significant effect on stock returns, interest rates have a significant effect on stock returns, the exchange rate have no significant effect on stock returns, capital structure have no significant effect on stock returns, and company size as a control variable do not have a significant effect on stock returns in pharmaceutical companies listed on the IDX for the 2015-2020 period.Keywords : Exchange Rates, Capital Structure, Inflation, Interest Rates, Stock Returns

Profitabilitas, Likuiditas, Modal Intelektual dan Nilai Perusahaan pada Masa Pandemi Covid-19

During the Covid-19 pandemic, the value of pharmaceutical companies increased while other companies didn't. This research aims to determine how profitability, liquidity, and intellectual capital influence firm value during the Covid-19 pandemic. The population in this research is 12 pharmaceutical sector companies listed on the Indonesia Stock Exchange (IDX) for the first quarter of 2020 to the second quarter of 2021. The sampling technique used the purposive sampling method with the number of samples obtained as many as 10 companies with 60 observations. This research used multiple linear regression analysis to determine the effect of profitability, liquidity, and intellectual capital on firm value during the Covid-19 pandemic. This research indicates that profitability, liquidity, and intellectual capital have a positive effect on firm value during the Covid-19 pandemic.
 Keywords: Profitability; Liquidity; Intellectual Capital; Firm Value.

НЕФИНАНСОВЫЕ ФАКТОРЫ ЭФФЕКТИВНОСТИ ФАРМАЦЕВТИЧЕСКИХ КОМПАНИЙ В РОССИИ

The development of the pharmaceutical industry is inextricably linked with the development of new types of drugs, the introduction of new technologies, the provision of scientific research in bioengineering and biotechnology, which can be ensured through the continuous development of intellectual capital. Intellectual capital is a capacious and ambiguous concept that, other things equal, is explained by the presence of professional skills and competencies of employees that cannot be separated from them and, therefore, are reflected in the financial statements. For a long time, researchers have been evaluating the impact of intellectual capital on the performance and value of companies in various sectors of economy. This article attempts to look at the problem more broadly by adding the factors inherent in sustainable development and competitive advantages of the company: business model and business strategy to the traditional elements of intellectual capital. The purpose of the work is to assess 137the impact of business strategy, business model and intellectual capital components on the performance of pharmaceutical companies in Russia. The object of the study is the financial and non-financial reporting of Russian pharmaceutical companies. The subject is establishing the relationship between the disclosure of information on intellectual capital and financial performance, taking into account the business strategy and business model of the company. The methodological basis is the statistical and economic method, namely, the regression of panel data with fixed effects. The results show that most large companies in pharmaceutical sector adhere to the business strategy of “analyzers” and choose the business model of producers of their own drugs. The findings indicate no connection between the company's business strategy and business model and the performance of pharmaceutical companies. Elements of IC have been established that provide competitive advantages for the company in pharmaceutical industry.

Stock Market Reaction of Pharmaceutical Sector Companies to the Announcement of the Covid 19 Endemic in Indonesia

Stock Market Reaction of Pharmaceutical Sector Companies to the Announcement of the Covid 19 Endemic in Indonesia

Analisis Kinerja Keuangan Sektor Farmasi Yang Terdaftar Di BEI Sebelum Dan Saat Covid-19

Financial performance is a reference that the company wants to achieve in the future within a certain period of time, which effectively and efficiently reflects the health of the company. This study aims to obtain information on the financial performance of pharmaceutical sector companies listed on the IDX before and during COVID-19. The research method used in this research is descriptive quantitative. The data analysis technique used is the profitability ratio with secondary data collection. The results of the analysis show that COVID-19 affects the financial performance of pharmaceutical sector companies listed on the Indonesia Stock Exchange. There are several companies experiencing an increase in profitability ratios before and during COVID-19, but not significantly. This supports the agency theory and the signal theory that management has managed the company effectively so that there is an increase in profits. A high profitability ratio is a good signal for investors to invest their shares in the company so that the value of the company's shares will rise.